We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Technique Might Cure High Blood Pressure

By HospiMedica International staff writers
Posted on 05 Jan 2010
A revolutionary new surgical system and procedure could reduce the risk of a major heart attack or stroke in those patients with persistent high blood pressure on whom medication has no effect.

The Symplicity Catheter System uses controlled, low-power radiofrequency (RF) energy to deactivate the renal nerves, thereby selectively reducing both the pathologic central sympathetic drive to the kidney, and the renal contribution to central sympathetic hyperactivity. More...
The system has two main components, designed to work together as an integrated system to ensure consistent performance. The first is the Symplicity catheter, a low profile energy delivery catheter that delivers RF energy through the arterial wall to the renal nerves, which has an atraumatic, radiopaque, tip that minimizes risk of arterial injury and is easily visualized under fluoroscopy. The second component is the Symplicity generator, a fully automated, compact, RF generator with hands-free pedal activation and built-in control mechanisms and temperature and impedance monitoring functions to protect against excess energy delivery.

The surgical procedure, called renal sympathetic-nerve ablation, is a minimally invasive procedure that takes about 40 minutes, and patients recover quickly and can soon return to their daily lives. The Symplicity Catheter System is under development by Ardian (Palo Alto, CA, USA), and is undergoing clinical studies in patients with resistant hypertension and chronic kidney disease in centers across the United States, Europe, and Australia.

"This is the most exciting development in hypertension since the advent of antihypertensive medication 50 years ago. It is hard to forecast the limitations and it could eventually be compared to medication,” said Mel Lobo, M.D., a specialist in clinical hypertension with the United Kingdom National Health Service (NHS, London, United Kingdom).

The renal sympathetic nerves have been identified as a major contributor to the complex pathophysiology of hypertension, in both experimental models and in humans. Patients with essential hypertension generally have increased efferent sympathetic drive to the kidneys, as evidenced by elevated rates of renal norepinephrine spillover into the circulation. Hypertension is also characterized by an increased rate of sympathetic-nerve firing, possibly modulated by afferent signaling from renal sensory nerves.

Related Links:
Ardian
United Kingdom National Health Service


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.